Steven Miller, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Oklahoma City, OKNPI 1508939232
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,836 of the $7,397 with a category attached, or 65.4%. 17 manufacturers reported payments, led by Medtronic at 46.6% of the total. Reporting peaked in 2019 at $6,242 and has fallen 97.1% since, to $181 in 2025.
Across 78 payments — averaging $94.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Edwards Lifesciences$2K
- Atricure, Inc.$1K
- Novo Nordisk$122
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$121
- Blue Earth Diagnostics$82
- plus $321 from 11 others
What the payments were for
- Travel & lodging$4,83665%
- Food & beverage$2,56035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $3,450 |
| Edwards Lifesciences | 13 | $1,951 |
| Atricure, Inc. | 14 | $1,349 |
| Novo Nordisk | 1 | $122 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $121 |
| Blue Earth Diagnostics | 4 | $82 |
| Endologix LLC | 2 | $73 |
| Abbott | 2 | $62 |
| Acera Surgical, Inc. | 2 | $38 |
| Abiomed | 1 | $29 |
| Innovation Technologies Inc | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $21 |
| Artivion, Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,397 in reported general payments places this provider in the 65th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 41 | $2,109 |
| Enoxaparin Sodium | 18 | $1,400 |
| ClopidogrelClopidogrel Bisulfate | 78 | $757 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $490 |
| Potassium Chloride | 33 | $192 |
| Metoprolol Succinate | 23 | $176 |
| Warfarin Sodium | 16 | $153 |
| Metoprolol Tartrate | 58 | $151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $111 |
| Oxycodone Hcl | 23 | $108 |
| Furosemide | 39 | $104 |
| Carvedilol | 17 | $92 |
| Atorvastatin Calcium | 21 | $76 |
| Methocarbamol | 19 | $70 |
| Lisinopril | 25 | $51 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Oklahoma City
- James LongOklahoma City$634K
- Charles ElkinsOklahoma City$42K
- James ReinersmanOklahoma City$40K
- David VanhooserOklahoma City$25K
- Michael CannonOklahoma City$18K
- Daniel FrenoOklahoma City$16K
- Jess SchwartzOklahoma City$16K
- Marshall BellOklahoma City$14K
- Jess ThompsonOklahoma City$5K
- Scott LucasOklahoma City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.